The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world effectiveness of nab-paclitaxel plus carboplatin as first-line therapy for patients with advanced NSCLC: Results of the second interim analysis of the NEPTUN study.
 
Tobias Nicolaas Dechow
No Relationships to Disclose
 
Jorge Riera-Knorrenschild
No Relationships to Disclose
 
Björn Hackanson
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer; Roche
Research Funding - Boehringer Ingelheim
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Holger Schulz
No Relationships to Disclose
 
Marco Chiabudini
No Relationships to Disclose
 
Barbara Timm
No Relationships to Disclose
 
Ralf Zerbes
No Relationships to Disclose
 
Karin Potthoff
No Relationships to Disclose